Latest Insider Transactions at Axonics, Inc. (AXNX)
This section provides a real-time view of insider transactions for Axonics, Inc. (AXNX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Axonics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Axonics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2022
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,094
-9.73%
|
$929,674
$71.13 P/Share
|
|
Jul 05
2022
|
Jane E Kiernan |
SELL
Open market or private sale
|
Direct |
5,250
-26.24%
|
$315,000
$60.0 P/Share
|
|
Apr 01
2022
|
Jane E Kiernan |
SELL
Open market or private sale
|
Direct |
1,750
-8.04%
|
$108,500
$62.71 P/Share
|
|
Mar 29
2022
|
Jane E Kiernan |
SELL
Open market or private sale
|
Direct |
5,250
-22.99%
|
$315,000
$60.75 P/Share
|
|
Mar 29
2022
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-20.52%
|
$3,000,000
$60.0 P/Share
|
|
Mar 18
2022
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,531
-24.34%
|
$771,267
$57.23 P/Share
|
|
Mar 14
2022
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-3.63%
|
$2,600,000
$52.65 P/Share
|
|
Mar 01
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
19,910
-19.21%
|
$1,134,870
$57.28 P/Share
|
|
Mar 01
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,329
+23.31%
|
$308,225
$25.82 P/Share
|
|
Feb 25
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-26.15%
|
$570,000
$57.0 P/Share
|
|
Feb 25
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.1%
|
$200,000
$20.01 P/Share
|
|
Feb 03
2022
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,115
-4.71%
|
$1,685,520
$48.62 P/Share
|
|
Feb 03
2022
|
Raymond W Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
96,846
+20.54%
|
-
|
|
Feb 03
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
18,684
-20.52%
|
$896,832
$48.62 P/Share
|
|
Feb 03
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,919
+44.04%
|
-
|
|
Feb 03
2022
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
9,267
-10.18%
|
$444,816
$48.62 P/Share
|
|
Feb 03
2022
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,130
+34.39%
|
-
|
|
Feb 03
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
6,251
-4.67%
|
$300,048
$48.62 P/Share
|
|
Feb 03
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,870
+23.69%
|
-
|
|
Feb 03
2022
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,882
-7.52%
|
$570,336
$48.62 P/Share
|
|
Feb 03
2022
|
Rinda Sama Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,311
+26.9%
|
-
|
|
Feb 03
2022
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,682
-5.4%
|
$320,736
$48.62 P/Share
|
|
Feb 03
2022
|
Karen Noblett Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,463
+23.81%
|
-
|
|
Feb 01
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
20,000
-20.25%
|
$960,000
$48.47 P/Share
|
|
Feb 01
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+40.0%
|
$280,000
$14.19 P/Share
|
|
Jan 31
2022
|
Raymond W Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,297
+13.48%
|
-
|
|
Jan 31
2022
|
Danny L. Dearen President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+34.38%
|
-
|
|
Jan 31
2022
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,285
+42.64%
|
-
|
|
Jan 31
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,425
+31.61%
|
-
|
|
Jan 31
2022
|
Rinda Sama Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,425
+29.86%
|
-
|
|
Jan 31
2022
|
Karen Noblett Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,350
+11.11%
|
-
|
|
Jan 18
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
20,000
-23.43%
|
$1,020,000
$51.21 P/Share
|
|
Jan 18
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.82%
|
$100,000
$5.75 P/Share
|
|
Nov 15
2021
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
5,000
-8.71%
|
$300,000
$60.42 P/Share
|
|
Nov 15
2021
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.31%
|
$70,000
$14.19 P/Share
|
|
Oct 22
2021
|
Robert Mc Namara |
BUY
Grant, award, or other acquisition
|
Direct |
2,261
+18.81%
|
-
|
|
Oct 22
2021
|
Michael H Carrel |
BUY
Grant, award, or other acquisition
|
Direct |
2,261
+14.57%
|
-
|
|
Oct 22
2021
|
Jane E Kiernan |
BUY
Grant, award, or other acquisition
|
Direct |
2,261
+14.97%
|
-
|
|
Oct 22
2021
|
David M Demski |
BUY
Grant, award, or other acquisition
|
Direct |
942
+17.5%
|
-
|
|
Oct 22
2021
|
Nancy Lynn Md Snyderman |
BUY
Grant, award, or other acquisition
|
Direct |
2,261
+13.22%
|
-
|
|
Sep 09
2021
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-17.57%
|
$3,850,000
$77.11 P/Share
|
|
Sep 02
2021
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
1,557
-5.88%
|
$116,775
$75.58 P/Share
|
|
Sep 01
2021
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
8,443
-24.17%
|
$624,782
$74.73 P/Share
|
|
Sep 01
2021
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+12.52%
|
$5,000
$1.63 P/Share
|
|
Aug 17
2021
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
25,000
-13.53%
|
$1,675,000
$67.53 P/Share
|
|
Aug 05
2021
|
Jane E Kiernan |
BUY
Exercise of conversion of derivative security
|
Direct |
14,167
+26.16%
|
$382,509
$27.57 P/Share
|
|
Jul 15
2021
|
Esteban Lopez |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+50.0%
|
-
|
|
Jun 11
2021
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,638
-8.37%
|
$155,642
$59.78 P/Share
|
|
Jun 11
2021
|
Rinda Sama Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,638
+7.72%
|
$36,932
$14.19 P/Share
|
|
Jun 10
2021
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,362
-4.5%
|
$81,720
$60.02 P/Share
|